The Magazine for Sleep Professionals
Wednesday, October 7, 2026
Masimo has announced the findings of a recently published study in which researchers investigated whether home pulse oximetry monitoring might be a useful initial screening method of determining which children with Down syndrome (DS) – who are at high risk of obstructive sleep apnea (OSA) – be recommended to undergo […]
Electromed, Inc. announced the results of an independent, outcome-based clinical study presented during the third annual World Bronchiectasis Conference in Washington D.C. The study’s findings reveal that early use of high-frequency chest wall oscillation (“HFCWO”) therapy with the SmartVest® Airway Clearance System significantly reduced severe exacerbations and hospitalizations among non-cystic […]
Wake Up Narcolepsy Awards Unrestricted Grants to Stanford And Harvard Narcolepsy Research At the SLEEP 2018 meeting held in early June, Wake Up Narcolepsy awarded Dr. Mignot from Stanford Center for Sleep Sciences and Medicine $45,000 for ongoing research. The funding allows Dr. Mignot to continue his pivotal research into […]
By Campbell Cauthen, BS, RRT-NPS For people with chronic obstructive pulmonary disease (COPD), getting to sleep — and sleeping through the night — can be a challenge. While a sufficient night’s rest is important for everyone, it is especially important for those dealing with the health challenges of COPD. For COPD […]
SleepScore Labs™, the company behind the most advanced non-contact sleep improvement system for consumers, has announced exciting results from its latest, scientific validation study. The study found that Swannies Blue Light Blocking Glasses from SleepScore ecosystem partner, Swanwick Sleep, contributed to measurably improved sleep quality when worn after sunset. SleepScore […]
More than 4 in 10 women with asthma may go on to develop chronic obstructive pulmonary disease (COPD), according to a study conducted in Ontario, Canada, and published online in the Annals of the American Thoracic Society. In “Asthma and COPD Overlap in Women: Incidence and Risk Factors,” Teresa To, […]
Vertex Pharmaceuticals Incorporated announced the U.S. Food and Drug Administration (FDA) has approved ORKAMBI® (lumacaftor/ivacaftor) to include use in children ages 2 through 5 years with cystic fibrosis (CF) who have two copies of the F508del-CFTR mutation, making it the first medicine approved to treat the underlying cause of CF […]
By Alicia Sanchez Lack of sleep plays an important role in appetite control and metabolism. While getting a good seven to nine hours of sleep can be difficult for anyone, those who work swing or night shifts are in the challenging position of working against the body’s circadian rhythms. Working […]
By Kaye Prather Whether you’re a respiratory therapist working in acute care, home health, outpatient pulmonary function, pulmonary rehab, research or sleep studies our patients ask us about their medications. Respiratory medications seem to be the most confusing and often missed in their daily routines. We don’t like to use […]
Inhaled vaporized cannabis does not appear to improve or worsen exercise performance and activity-related breathlessness in patients with advanced chronic obstructive pulmonary disease (COPD), according to a randomized controlled trial published online in the Annals of the American Thoracic Society. In “Effect of Vaporized Cannabis on Exertional Breathlessness and Exercise […]
